Index

hydralazine, 111, 236, 247, 248 hydration, 87, 122, 131, 151, 210, 253, 277 pressure ulcers and, 210

hydration status, 82, 83, 109, 214, 215, 220 assessment of, 122, 125–126, 215 hypercalcemia, 225, 226, 241, 282 hyperglycemia, 176, 177, 181, 185, 194, 221, 222, 225, 226, 250

hyperkalemia, 173, 226, 241, 250 hyperlipidemia, 98, 228, 229, 247 hypermagnesemia, 250

hypernatremia, 123, 225, 226, 250 hyperosmolar hyperglycemic state (HHS), 181 hyperphosphatemia, 171, 231, 250 hypertension, 75, 77, 137, 166, 171, 180, 223, 228, 229, 241

chronic kidney disease and, 169, 171 hyperthyroidism, 109, 164, 166, 221, 222, 227, 229

hypertonic dehydration, 129, 130 hypertriglyceridemia, 194, 250 hypoalbuminemia, 171, 237, 253 hypocalcemia, 171

hypoglossal nerves, 139, 143, 146 hypoglycemia, 238, 250, 262 hypokalemia, 127, 173, 226, 241, 250 hypomagnesemia, 241, 250 hyponatremia, 128, 225, 227, 241, 250 hypophosphatemia, 250 hyposmia, 250

hypothyroidism, 85, 164, 166, 221, 228, 229 hypotonic dehydration, 127–129

IBD. See inflammatory bowel disease (IBD) ideal body weight (IBW), 81, 94 immune system, 4, 9, 155 incontinence, 5, 40, 77, 199, 306 infections, 86–87, 109, 125, 191 inflammation, 9

anemia of, 162–163

inflammatory bowel disease (IBD), 167 Informal Dispute Resolution (IDR), 317 information and referral services, 52 infusion pump, 258, 262 inner lip plate, 41

Institute for Caregiver Education, 31 Institute for Healthcare Improvement, 331 Institute of Medicine, 10, 22, 30, 337, 340, 351 instrumental activities of daily living, 159

391

insulin, 5, 176, 179, 180, 181, 183, 185, 222, 225, 228, 239

insurance, 347 integrative therapy, 192. See also complementary and alternative medicine (CAM) cancer, 289

INTERACT/INTERACT II, 289 International Dietetics and Nutrition Terminology (IDNT) Reference Manual, 50, 57. See also electronic Nutrition Care Process Terminology (eNCPT)

international units (SI units), 216 Interventions to Reduce Acute Care Transfers. See INTERACT/INTERACT II

intracellular fluid (ICF), 123–124, 129, 225, 226 intravenous feeding. See parenteral nutrition (PN) intrinsic factor (IF), 164, 228 involuntary weight loss (IWL). See unintended weight loss (UWL) iodine, 12

iron, 6, 12, 98–99, 111, 139, 175, 194, 246–247 anemias and, 83, 159, 160, 161–162, 163, 172 drug interactions, 172, 241, 249 lab tests, 166, 222, 223, 224 iron deficiency, 161 iron therapy, 161–162, 224

isoniazid, 216, 219, 221, 225, 229, 236, 248 isotonic dehydration, 127, 128 isotonic tube feeding, 258

jejunostomy feeding tube, 256, 259 Joint Commission, 337, 348, 361, 362

kidney disease. See chronic kidney disease (CKD) kidneys, 124, 171, 185, 235, 237 kidneys, age-related changes, 169 Korsakoff’s psychosis, 238 Krumholz, Harlan, 288

laboratory assessment, 214–231 alanine aminotransferase (ALT), 216 albumin, 215, 217, 227, 228

anemia, 217, 220, 222, 223, 224, 228, 229 aspartate aminotransferase, 216, 218, 219 blood urea nitrogen (BUN), 215, 218, 219, 220

case studies, 230–231 cholesterol, 228–229 cost effectiveness, 216